Results 151 to 160 of about 2,198,221 (190)

First Case of Echinocandin-ResistantCandida albicansin Korea

Annals of Laboratory Medicine, 2017
Park, Min-Seung, Park, Jong Eun, Song, Dong Joon, Huh, Hee Jae, Park, Silvia, Kang, Cheol-In, Shin, Jong Hee, Lee, Nam Yong   +7 more
openaire   +1 more source

Isolation and characterization of echinocandin resistant Candida albicans mutants

, 1997
LY303366 (LY) is an investigational echinocandin that has demonstrated activity against Candida species. We attempted to isolate an LY resistant mutant by plating the C. albicans clinical strain Y41 at a concentration of 10$\sp7$ CFU/plate on Brain Heart Infusion agar (BHI) plates supplemented with LY at concentrations of 1 to 40 $\mu$g/ml.
openaire   +1 more source

Rapid Detection of ERG11-Associated Azole Resistance and FKS-Associated Echinocandin Resistance in Candida auris. [PDF]

Antimicrob Agents Chemother, 2019
Hou X, Lee A, Jiménez-Ortigosa C, Kordalewska M, Perlin DS, Zhao Y.   +5 more
europepmc   +1 more source

Amphotericin B Induction with Voriconazole Consolidation as Salvage Therapy for FKS-Associated Echinocandin Resistance in Candida glabrata Septic Arthritis and Osteomyelitis. [PDF]

Antimicrob Agents Chemother, 2019
Wright WF, Bejou N, Shields RK, Marr K, McCarty TP, Pappas PG.   +5 more
europepmc   +1 more source

Echinocandin resistance among Candida isolates at an academic medical centre 2005-15: analysis of trends and outcomes. [PDF]

J Antimicrob Chemother, 2018
McCarty TP, Lockhart SR, Moser SA, Whiddon J, Zurko J, Pham CD, Pappas PG.   +6 more
europepmc   +1 more source

Mitochondrial characteristics of echinocandin tolerance and resistance in <i>Candida glabrata</i> and <i>Candida krusei</i>. [PDF]

Front Microbiol
Xue P, Zhang L, Du M, Yuan Q, He H, Xue X, Liao W, Ma Y, Pan W, Cai L.   +9 more
europepmc   +1 more source

Natural Product-Inspired Antifungal Drugs Introduced for Human Use from 1872 to August 2026. [PDF]

Antibiotics (Basel)
Butler MS, Capon RJ.
europepmc   +1 more source